Hospital groups have dismissed the Bucshon bill, with 340B Health’s Testoni calling it “the legislative version of a pharmaceutical industry wish list,” and arguing it would gut the program. “The 340B Access Act is a nonstarter,” said Aimee Kuhlman, vice president of advocacy and grassroots at the AHA. “It’s really hard to negotiate when one […]